Mei D. Jiang

251#, Yaojiayuan Road, Chaoyang
Beijing, 100026, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Clinical significance of circulating FcγRIIa in the prognosis of patients with metastatic non-small cell lung cancer.

Clinical significance of circulating FcγRIIa in the prognosis of patients with metastatic non-small cell lung cancer.

Journal: Journal of cancer research and clinical oncology

Published: February 05, 2026

Delayed but durable remission to rituximab in PLA2R-associated membranous nephropathy despite B-cell reconstitution: a case report.

Delayed but durable remission to rituximab in PLA2R-associated membranous nephropathy despite B-cell reconstitution: a case report.

Journal: BMC nephrology

Published: January 06, 2026

Single-cell transcriptomics uncovers heterogenous cell clusters and the biomarker FUT11 in ovarian cancer progression.

Single-cell transcriptomics uncovers heterogenous cell clusters and the biomarker FUT11 in ovarian cancer progression.

Journal: Cancer cell international

Published: November 13, 2025

Exhausted CD8⁺ T cells promote ovarian cancer immunosuppression via CCL3-Driven M2 macrophage polarization.

Exhausted CD8⁺ T cells promote ovarian cancer immunosuppression via CCL3-Driven M2 macrophage polarization.

Journal: Cell death & disease

Published: November 10, 2025

LAPTM5 drives omental metastasis in high-grade serous ovarian cancer via TGF-β/Smad-mediated epithelial plasticity.

LAPTM5 drives omental metastasis in high-grade serous ovarian cancer via TGF-β/Smad-mediated epithelial plasticity.

Journal: Journal of translational medicine

Published: August 21, 2025

Targeting SPP1+ macrophages via the SPP1-CD44 axis reveals a key mechanism of immune suppression and tumor progression in ovarian cancer.

Targeting SPP1+ macrophages via the SPP1-CD44 axis reveals a key mechanism of immune suppression and tumor progression in ovarian cancer.

Journal: International immunopharmacology

Published: March 13, 2025

Spatially Coordinated Delivery of siRNA and Peptide Antagonist by Using Quantum Dots for Synergetic Cancer Therapy.

Spatially Coordinated Delivery of siRNA and Peptide Antagonist by Using Quantum Dots for Synergetic Cancer Therapy.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: January 24, 2025

Single-cell and spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer.

Single-cell and spatial transcriptome sequencing uncover a platinum-resistant cluster overexpressed TACSTD2 in high-grade serous ovarian cancer.

Journal: Journal of Cancer

Published: February 12, 2024

Single-cell transcriptomics identify TNFRSF1B as a novel T-cell exhaustion marker for ovarian cancer.

Single-cell transcriptomics identify TNFRSF1B as a novel T-cell exhaustion marker for ovarian cancer.

Journal: Clinical and translational medicine

Published: May 03, 2023

Mutation status analysis of 58 patients with advanced ALK fusion gene positive non small cell lung cancer.

Mutation status analysis of 58 patients with advanced ALK fusion gene positive non small cell lung cancer.

Journal: BMC pulmonary medicine

Published: March 05, 2023

Clinical characteristics of protracted bacterial bronchitis in adults.

Clinical characteristics of protracted bacterial bronchitis in adults.

Journal: Heliyon

Published: May 17, 2022

A nucleus-targeting peptide antagonist towards EZH2 displays therapeutic efficacy for lung cancer.

A nucleus-targeting peptide antagonist towards EZH2 displays therapeutic efficacy for lung cancer.

Journal: International journal of pharmaceutics

Published: March 02, 2022

Showing 1-12 of 39

Last Updated: 09/26/2026